Asthma treatment

http://www.healasthma.com past six monthsthe past twelve months Search Hint Connecting terms with OR broadens your search to give more results …more on search operators – . US Fed News (USA) – U.S. BANS OZONE-DEPLETING INHALERS AFTER WASHINGTON, — The U.S. Department of State’s International Information Programs issued the following press release Distribution of the medication albuterol in metered-dose inhalers pressurized with ozone-depleting substances will be banned after under a final rule adopted by the U.S. Food and Drug Administration (FDA) .The rule fulfills the agency’s obligations under both the federal Clean Air Act and the Montreal Protocol on… Medications on fire engines speed aid, By Patty Brandl A recent policy change that permits certain life-saving medications to be carried aboard Fond du Lac fire engines can lead to faster treatment for some critical patients.A combination of Wisconsin laws and local medical authorization allows trained emergency response teams to administer glucagon and albuterol at the scene, said St. Agnes Hospital Emergency Medical Services Coordinator Nettie Jenkins.Glucagon, a medication that treats low blood sugar, and albuterol, a bronchodilator… School medicine policy defies logic_and doctor Danna Bransky is afraid that if she leaves her house, her daughter might die.Or, to be judgmental, she might be allowed to die by Bensenville School District .Bransky’s -year-old daughter, Lindsey, has asthma. To combat her occasional attacks, she takes Albuterol, a bronchial inhaler used by people with severe asthma. When their throats tighten up, it allows them to breathe again.Not that Lindsey carries the medicine, for instance in a backpack, where it would be… NEW TREATMENT HELPS CHILDREN WITH ASTHMA NORFOLK, Va. Adding another medicine to the traditional two-drug treatment for severe childhood asthma attacks substantially reduces the need to hospitalize sufferers, according to a study published today.Researchers examined the effect of adding ipratropium bromide to the standard emergency room therapy for asthma attacks, albuterol and steroids.The result was a percent drop in the need for hospitalization, according to the study in today’s New England Journal of… . Los Angeles Times – Regular Daily Use of Beta-Agonists for Mild Asthma Found to Be Safe A major new study shows that, contrary to previously published reports, regular daily use of so-called beta-agonists such as albuterol for mild asthma does no harm to patients. The study, reported in the Sept. New England Journal of Medicine, also found, however, that such regular use is no more effective than use on an as-needed basis.”This study should lay to rest the concerns of more than million Americans with mild asthma–and their physicians–about the safety and… . INHALER USE QUESTIONED IN DEATH CASE By Steve DeVane Staff writer An Army medic told Pfc. Ennis Wallace that he wasn’t properly using an inhaler less than two hours before Wallace died from an overdose of a substance used to treat asthma, according to records. Wallace, a South Carolina National Guardsman, died while training at Camp Mackall. Friday is the first anniversary of his death. An investigation into his death determined that he died from albuterol intoxication. The death was… . SEPRACOR HOPES TO ADD ANOTHER ALLIANCE IN BOSTON – After a pivotal year of discoveries and deals, Sepracor Inc. is looking to fill out by adding another corporate alliance to its portfolio, starting additional drug studies and collecting more revenue from corporate partners.Chief Executive Timothy J. Barberich said yesterday that a string of corporate accomplishments last year, including the completion of encouraging studies on an improved version of a billion-dollar asthma drug, has set the stage for a second decade of work… . Boston Globe – NEW CHARGES SURFACE Copley Pharmaceutical Inc., canton-based maker of generic drugs, declined to comment on a report that it failed to follow the exact procedures it had promised federal regulators in order to prevent bacterial contamination of an asthma drug. Last , Copley’s generic liquid asthma medication labeled Albuterol Sulfate Inhalation . percent was recalled by the Federal Drug Administration after Copley notified the FDA the company had discovered bacterial contamination in one of… . THE – SAN FRANCISCO Million Lawsuit Over Reaction to Drug A million lawsuit was filed yesterday on behalf of a Bay Area woman who died and six other people who were hospitalized after inhaling a prescription drug for asthma.The suit in U.S. District Court in San Francisco accuses Copley Pharmaceutical Inc. of Canton, Mass., of negligently allowing its “albuterol sulfate” drug to become contaminated with an extremely potent and rare form of bacteria.Copley has recalled the generic drug, which is sold under… . Chemical Business NewsBase Press Release (United Kingdom) – Chemical Business NewsBase – Press Release Perforomist inhalation solution data in patients with moderate to severe COPD to be presented at the International Conference of the American Thoracic Society. Data from two presentations highlighting the use of Perforomist (formoterol fumarate) Inhalation Solution in moderate to severe chronic obstructive pulmonary disease (COPD) patients were featured at the International Conference of the American Thoracic Society in San Diego. In one analysis, use of Perforomist Inhalation Solution, when added to maintenance tiotropium, resulted in improved pulmonary function, dyspnea (shortness of breath) and rescue medication use versus treatment with tiotropium… –